Infinity to Present at Deutsche Bank Securities’ 2012 dbAccess Biofest

  Infinity to Present at Deutsche Bank Securities’ 2012 dbAccess Biofest

Business Wire

CAMBRIDGE, Mass. -- November 26, 2012

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 2012
dbAccess Biofest on December 3, 2012 at 1:40 p.m. ET in Boston.

A live webcast of this Infinity presentation will be accessible on the
Investors/Media section of Infinity's website at www.infi.com, and will be
available for 30 days following the event.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to
discover, develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.

Contact:

Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Kate.Murray@infi.com
http://www.infi.com